Gene symbol: Chrna7

Also known as: BTX; NARAD; nAChRa7

Organism: Rattus norvegicus

Summary: Enables several functions, including acetylcholine binding activity; acetylcholine-gated cation-selective channel activity; and enzyme binding activity. Involved in several processes, including dopamine biosynthetic process; neuronal action potential; and regulation of ERK1 and ERK2 cascade. Acts upstream of or within calcium ion transport and regulation of membrane potential. Located in several cellular components, including dendrite; plasma membrane raft; and postsynaptic density. Part of acetylcholine-gated channel complex. Is active in cholinergic synapse and glycinergic synapse. Is integral component of postsynaptic specialization membrane; integral component of presynaptic membrane; and integral component of spine apparatus membrane. Human ortholog(s) of this gene implicated in schizophrenia. Orthologous to several human genes including CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 25302 Ensembl:ENSRNOG00000010853 AllianceGenome:RGD:2348


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000902 Cell morphogenesis
Process GO:0000904 Cell morphogenesis involved in differentiation
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0001508 Action potential
Process GO:0001539 Cilium or flagellum-dependent cell motility
Process GO:0001666 Response to hypoxia
Process GO:0001775 Cell activation
Process GO:0001817 Regulation of cytokine production
Process GO:0001818 Negative regulation of cytokine production
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001933 Negative regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001976 Nervous system process involved in regulation of systemic arterial blood pressure
Process GO:0001978 Regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback
Process GO:0001982 Baroreceptor response to decreased systemic arterial blood pressure
Process GO:0001988 Positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure
Process GO:0002027 Regulation of heart rate
Process GO:0002376 Immune system process
Process GO:0003008 System process
Process GO:0003013 Circulatory system process
Process GO:0003025 Regulation of systemic arterial blood pressure by baroreceptor feedback
Process GO:0003073 Regulation of systemic arterial blood pressure
Process GO:0003084 Positive regulation of systemic arterial blood pressure
Process GO:0003341 Cilium movement
Process GO:0006576 Cellular biogenic amine metabolic process
Process GO:0006584 Catecholamine metabolic process
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006816 Calcium ion transport
Process GO:0006873 Cellular ion homeostasis
Process GO:0006874 Cellular calcium ion homeostasis
Process GO:0006875 Cellular metal ion homeostasis
Process GO:0006897 Endocytosis
Process GO:0006950 Response to stress
Process GO:0007017 Microtubule-based process
Process GO:0007018 Microtubule-based movement
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007267 Cell-cell signaling
Process GO:0007268 Chemical synaptic transmission
Process GO:0007271 Synaptic transmission, cholinergic
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007600 Sensory perception
Process GO:0007610 Behavior
Process GO:0007611 Learning or memory
Process GO:0007612 Learning
Process GO:0007613 Memory
Process GO:0008015 Blood circulation
Process GO:0008016 Regulation of heart contraction
Process GO:0008152 Metabolic process
Process GO:0008217 Regulation of blood pressure
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008306 Associative learning
Process GO:0009058 Biosynthetic process
Process GO:0009266 Response to temperature stimulus
Process GO:0009308 Amine metabolic process
Process GO:0009309 Amine biosynthetic process
Process GO:0009409 Response to cold
Process GO:0009605 Response to external stimulus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009712 Catechol-containing compound metabolic process
Process GO:0009713 Catechol-containing compound biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0009991 Response to extracellular stimulus
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010460 Positive regulation of heart rate
Process GO:0010468 Regulation of gene expression
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010563 Negative regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010629 Negative regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010941 Regulation of cell death
Process GO:0014061 Regulation of norepinephrine secretion
Process GO:0016043 Cellular component organization
Process GO:0016192 Vesicle-mediated transport
Process GO:0016358 Dendrite development
Process GO:0017157 Regulation of exocytosis
Process GO:0018958 Phenol-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019226 Transmission of nerve impulse
Process GO:0019228 Neuronal action potential
Process GO:0019438 Aromatic compound biosynthetic process
Process GO:0019725 Cellular homeostasis
Process GO:0022008 Neurogenesis
Process GO:0022414 Reproductive process
Process GO:0022602 Ovulation cycle process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030001 Metal ion transport
Process GO:0030003 Cellular cation homeostasis
Process GO:0030030 Cell projection organization
Process GO:0030154 Cell differentiation
Process GO:0030182 Neuron differentiation
Process GO:0030317 Flagellated sperm motility
Process GO:0030534 Adult behavior
Process GO:0031175 Neuron projection development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031347 Regulation of defense response
Process GO:0031348 Negative regulation of defense response
Process GO:0031399 Regulation of protein modification process
Process GO:0031400 Negative regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031644 Regulation of nervous system process
Process GO:0031667 Response to nutrient levels
Process GO:0032094 Response to food
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032102 Negative regulation of response to external stimulus
Process GO:0032225 Regulation of synaptic transmission, dopaminergic
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032651 Regulation of interleukin-1 beta production
Process GO:0032652 Regulation of interleukin-1 production
Process GO:0032675 Regulation of interleukin-6 production
Process GO:0032680 Regulation of tumor necrosis factor production
Process GO:0032691 Negative regulation of interleukin-1 beta production
Process GO:0032692 Negative regulation of interleukin-1 production
Process GO:0032715 Negative regulation of interleukin-6 production
Process GO:0032720 Negative regulation of tumor necrosis factor production
Process GO:0032879 Regulation of localization
Process GO:0032989 Cellular component morphogenesis
Process GO:0032990 Cell part morphogenesis
Process GO:0033135 Regulation of peptidyl-serine phosphorylation
Process GO:0033138 Positive regulation of peptidyl-serine phosphorylation
Process GO:0034220 Ion transmembrane transport
Process GO:0034248 Regulation of cellular amide metabolic process
Process GO:0034249 Negative regulation of cellular amide metabolic process
Process GO:0034250 Positive regulation of cellular amide metabolic process
Process GO:0034330 Cell junction organization
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0035094 Response to nicotine
Process GO:0035095 Behavioral response to nicotine
Process GO:0035637 Multicellular organismal signaling
Process GO:0036293 Response to decreased oxygen levels
Process GO:0042110 T cell activation
Process GO:0042113 B cell activation
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042326 Negative regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042391 Regulation of membrane potential
Process GO:0042401 Cellular biogenic amine biosynthetic process
Process GO:0042416 Dopamine biosynthetic process
Process GO:0042417 Dopamine metabolic process
Process GO:0042423 Catecholamine biosynthetic process
Process GO:0042592 Homeostatic process
Process GO:0042698 Ovulation cycle
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043409 Negative regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0044057 Regulation of system process
Process GO:0044093 Positive regulation of molecular function
Process GO:0044106 Cellular amine metabolic process
Process GO:0044237 Cellular metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0045321 Leukocyte activation
Process GO:0045471 Response to ethanol
Process GO:0045765 Regulation of angiogenesis
Process GO:0045766 Positive regulation of angiogenesis
Process GO:0045777 Positive regulation of blood pressure
Process GO:0045823 Positive regulation of heart contraction
Process GO:0045936 Negative regulation of phosphate metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0046189 Phenol-containing compound biosynthetic process
Process GO:0046649 Lymphocyte activation
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0048149 Behavioral response to ethanol
Process GO:0048167 Regulation of synaptic plasticity
Process GO:0048468 Cell development
Process GO:0048511 Rhythmic process
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048666 Neuron development
Process GO:0048667 Cell morphogenesis involved in neuron differentiation
Process GO:0048699 Generation of neurons
Process GO:0048731 System development
Process GO:0048812 Neuron projection morphogenesis
Process GO:0048813 Dendrite morphogenesis
Process GO:0048856 Anatomical structure development
Process GO:0048858 Cell projection morphogenesis
Process GO:0048869 Cellular developmental process
Process GO:0048870 Cell motility
Process GO:0048878 Chemical homeostasis
Process GO:0050433 Regulation of catecholamine secretion
Process GO:0050727 Regulation of inflammatory response
Process GO:0050728 Negative regulation of inflammatory response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050801 Ion homeostasis
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050806 Positive regulation of synaptic transmission
Process GO:0050808 Synapse organization
Process GO:0050877 Nervous system process
Process GO:0050890 Cognition
Process GO:0050893 Sensory processing
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051094 Positive regulation of developmental process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051716 Cellular response to stimulus
Process GO:0051899 Membrane depolarization
Process GO:0051952 Regulation of amine transport
Process GO:0055065 Metal ion homeostasis
Process GO:0055074 Calcium ion homeostasis
Process GO:0055080 Cation homeostasis
Process GO:0055082 Cellular chemical homeostasis
Process GO:0055085 Transmembrane transport
Process GO:0060078 Regulation of postsynaptic membrane potential
Process GO:0060079 Excitatory postsynaptic potential
Process GO:0060112 Generation of ovulation cycle rhythm
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060285 Cilium-dependent cell motility
Process GO:0060294 Cilium movement involved in cell motility
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070373 Negative regulation of ERK1 and ERK2 cascade
Process GO:0070374 Positive regulation of ERK1 and ERK2 cascade
Process GO:0070482 Response to oxygen levels
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072503 Cellular divalent inorganic cation homeostasis
Process GO:0072507 Divalent inorganic cation homeostasis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0095500 Acetylcholine receptor signaling pathway
Process GO:0097061 Dendritic spine organization
Process GO:0097305 Response to alcohol
Process GO:0097722 Sperm motility
Process GO:0098655 Cation transmembrane transport
Process GO:0098771 Inorganic ion homeostasis
Process GO:0098815 Modulation of excitatory postsynaptic potential
Process GO:0098916 Anterograde trans-synaptic signaling
Process GO:0098926 Postsynaptic signal transduction
Process GO:0099173 Postsynapse organization
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0099536 Synaptic signaling
Process GO:0099537 Trans-synaptic signaling
Process GO:0099565 Chemical synaptic transmission, postsynaptic
Process GO:0106027 Neuron projection organization
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0120039 Plasma membrane bounded cell projection morphogenesis
Process GO:0140058 Neuron projection arborization
Process GO:0140059 Dendrite arborization
Process GO:1900271 Regulation of long-term synaptic potentiation
Process GO:1900273 Positive regulation of long-term synaptic potentiation
Process GO:1901214 Regulation of neuron death
Process GO:1901342 Regulation of vasculature development
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901362 Organic cyclic compound biosynthetic process
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901566 Organonitrogen compound biosynthetic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901615 Organic hydroxy compound metabolic process
Process GO:1901617 Organic hydroxy compound biosynthetic process
Process GO:1901652 Response to peptide
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902003 Regulation of amyloid-beta formation
Process GO:1902004 Positive regulation of amyloid-beta formation
Process GO:1902430 Negative regulation of amyloid-beta formation
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902903 Regulation of supramolecular fiber organization
Process GO:1902991 Regulation of amyloid precursor protein catabolic process
Process GO:1902992 Negative regulation of amyloid precursor protein catabolic process
Process GO:1902993 Positive regulation of amyloid precursor protein catabolic process
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903522 Regulation of blood circulation
Process GO:1903524 Positive regulation of blood circulation
Process GO:1903530 Regulation of secretion by cell
Process GO:1903555 Regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903556 Negative regulation of tumor necrosis factor superfamily cytokine production
Process GO:1904018 Positive regulation of vasculature development
Process GO:1904645 Response to amyloid-beta
Process GO:1905114 Cell surface receptor signaling pathway involved in cell-cell signaling
Process GO:1905144 Response to acetylcholine
Process GO:1905145 Cellular response to acetylcholine
Process GO:1905906 Regulation of amyloid fibril formation
Process GO:1905918 Regulation of CoA-transferase activity
Process GO:1905920 Positive regulation of CoA-transferase activity
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000300 Regulation of synaptic vesicle exocytosis
Process GO:2000463 Positive regulation of excitatory postsynaptic potential
Process GO:2001023 Regulation of response to drug
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0005892 Acetylcholine-gated channel complex
Component GO:0009897 External side of plasma membrane
Component GO:0009986 Cell surface
Component GO:0012505 Endomembrane system
Component GO:0014069 Postsynaptic density
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0016324 Apical plasma membrane
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0030425 Dendrite
Component GO:0030426 Growth cone
Component GO:0030427 Site of polarized growth
Component GO:0030673 Axolemma
Component GO:0031090 Organelle membrane
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0031252 Cell leading edge
Component GO:0031253 Cell projection membrane
Component GO:0031256 Leading edge membrane
Component GO:0031300 Intrinsic component of organelle membrane
Component GO:0031301 Integral component of organelle membrane
Component GO:0032279 Asymmetric synapse
Component GO:0032589 Neuron projection membrane
Component GO:0032991 Protein-containing complex
Component GO:0034702 Ion channel complex
Component GO:0036477 Somatodendritic compartment
Component GO:0042734 Presynaptic membrane
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043197 Dendritic spine
Component GO:0043198 Dendritic shaft
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043235 Receptor complex
Component GO:0044297 Cell body
Component GO:0044304 Main axon
Component GO:0044309 Neuron spine
Component GO:0044853 Plasma membrane raft
Component GO:0045121 Membrane raft
Component GO:0045177 Apical part of cell
Component GO:0045202 Synapse
Component GO:0045211 Postsynaptic membrane
Component GO:0070161 Anchoring junction
Component GO:0071944 Cell periphery
Component GO:0097060 Synaptic membrane
Component GO:0097444 Spine apparatus
Component GO:0097447 Dendritic tree
Component GO:0098552 Side of membrane
Component GO:0098588 Bounding membrane of organelle
Component GO:0098590 Plasma membrane region
Component GO:0098690 Glycinergic synapse
Component GO:0098793 Presynapse
Component GO:0098794 Postsynapse
Component GO:0098796 Membrane protein complex
Component GO:0098797 Plasma membrane protein complex
Component GO:0098802 Plasma membrane signaling receptor complex
Component GO:0098857 Membrane microdomain
Component GO:0098889 Intrinsic component of presynaptic membrane
Component GO:0098897 Spine apparatus membrane
Component GO:0098936 Intrinsic component of postsynaptic membrane
Component GO:0098948 Intrinsic component of postsynaptic specialization membrane
Component GO:0098952 Intrinsic component of spine apparatus membrane
Component GO:0098981 Cholinergic synapse
Component GO:0098984 Neuron to neuron synapse
Component GO:0099055 Integral component of postsynaptic membrane
Component GO:0099056 Integral component of presynaptic membrane
Component GO:0099060 Integral component of postsynaptic specialization membrane
Component GO:0099065 Integral component of spine apparatus membrane
Component GO:0099240 Intrinsic component of synaptic membrane
Component GO:0099572 Postsynaptic specialization
Component GO:0099634 Postsynaptic specialization membrane
Component GO:0099699 Integral component of synaptic membrane
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0150034 Distal axon
Component GO:1902495 Transmembrane transporter complex
Component GO:1990351 Transporter complex
Function GO:0001540 Amyloid-beta binding
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0005215 Transporter activity
Function GO:0005216 Ion channel activity
Function GO:0005230 Extracellular ligand-gated ion channel activity
Function GO:0005231 Excitatory extracellular ligand-gated ion channel activity
Function GO:0005261 Cation channel activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008179 Adenylate cyclase binding
Function GO:0008324 Cation transmembrane transporter activity
Function GO:0015075 Ion transmembrane transporter activity
Function GO:0015267 Channel activity
Function GO:0015276 Ligand-gated ion channel activity
Function GO:0015318 Inorganic molecular entity transmembrane transporter activity
Function GO:0015464 Acetylcholine receptor activity
Function GO:0015643 Toxic substance binding
Function GO:0016247 Channel regulator activity
Function GO:0017081 Chloride channel regulator activity
Function GO:0019899 Enzyme binding
Function GO:0019900 Kinase binding
Function GO:0019901 Protein kinase binding
Function GO:0022803 Passive transmembrane transporter activity
Function GO:0022824 Transmitter-gated ion channel activity
Function GO:0022834 Ligand-gated channel activity
Function GO:0022835 Transmitter-gated channel activity
Function GO:0022836 Gated channel activity
Function GO:0022848 Acetylcholine-gated cation-selective channel activity
Function GO:0022857 Transmembrane transporter activity
Function GO:0022890 Inorganic cation transmembrane transporter activity
Function GO:0030594 Neurotransmitter receptor activity
Function GO:0033218 Amide binding
Function GO:0038023 Signaling receptor activity
Function GO:0042165 Neurotransmitter binding
Function GO:0042166 Acetylcholine binding
Function GO:0042277 Peptide binding
Function GO:0042802 Identical protein binding
Function GO:0042803 Protein homodimerization activity
Function GO:0043167 Ion binding
Function GO:0043169 Cation binding
Function GO:0046983 Protein dimerization activity
Function GO:0051117 ATPase binding
Function GO:0060089 Molecular transducer activity
Function GO:0097110 Scaffold protein binding
Function GO:0098772 Molecular function regulator activity
Function GO:0098960 Postsynaptic neurotransmitter receptor activity
Function GO:0099094 Ligand-gated cation channel activity
Function GO:0099106 Ion channel regulator activity
Function GO:0099529 Neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential
Function GO:1904315 Transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential

Pathway annotation


Category Term ID Term description
RCTM RNO-112314 Neurotransmitter receptors and postsynaptic signal transmission
RCTM RNO-112315 Transmission across Chemical Synapses
RCTM RNO-112316 Neuronal System
RCTM RNO-181431 Acetylcholine binding and downstream events
RCTM RNO-622327 Postsynaptic nicotinic acetylcholine receptors
RCTM RNO-629594 Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
KEGG rno04020 Calcium signaling pathway
KEGG rno04080 Neuroactive ligand-receptor interaction
KEGG rno04725 Cholinergic synapse
KEGG rno05010 Alzheimer disease
KEGG rno05022 Pathways of neurodegeneration - multiple diseases
KEGG rno05033 Nicotine addiction
KEGG rno05207 Chemical carcinogenesis - receptor activation

Expression profile of Chrna7 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 7.52369135
GSM2685202 MX2 tissue: Myocardium gender: female 6.0169685
GSM2685203 MX3 tissue: Myocardium gender: female 6.4397415
GSM2685204 MX4 tissue: Myocardium gender: male 6.7616955
GSM2685205 DZ1 tissue: Myocardium gender: male 5.96395415
GSM2685206 DZ2 tissue: Myocardium gender: male 5.2507677
GSM2685207 DZ3 tissue: Myocardium gender: female 5.7913179999999995
GSM2685208 DZ4 tissue: Myocardium gender: female 5.983091750000001
GSM2685209 JJ1 tissue: Myocardium gender: male 6.796327
GSM2685210 JJ2 tissue: Myocardium gender: female 7.0357375
GSM2685211 JJ3 tissue: Myocardium gender: female 7.223106400000001
GSM2685212 JJ4 tissue: Myocardium gender: male 7.288653500000001
GSM2685213 NG1 tissue: Myocardium gender: male 7.905906
GSM2685214 NG2 tissue: Myocardium gender: female 6.44557625
GSM2685215 NG3 tissue: Myocardium gender: male 7.4345314
GSM2685216 NG4 tissue: Myocardium gender: female 6.76602425
GSM2685217 YL1 tissue: Myocardium gender: male 6.12589375
GSM2685218 YL2 tissue: Myocardium gender: male 6.982403
GSM2685219 YL3 tissue: Myocardium gender: female 6.6949483
GSM2685220 YL4 tissue: Myocardium gender: female 5.94647015
GSM2685221 QC1 tissue: Myocardium gender: male 5.73411205
GSM2685222 QC2 tissue: Myocardium gender: male 6.5408945
GSM2685223 QC3 tissue: Myocardium gender: female 6.4787145
GSM2685224 QC4 tissue: Myocardium gender: female 6.58980775

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.889664007
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.951680129
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.88922558
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.475347172
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.578236715
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.063555501

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 8.143531
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.91517
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.906907
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.887416
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 8.067079
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 8.009035

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 16.39
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 14.477
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 15.055
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 17.644
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 16.696

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 7.035849858
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 7.051844078
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 6.355272688

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 82.9
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 93.60000000000001
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 107.26666666666667
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 101.66666666666667
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 46.53333333333333
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 93.03333333333332
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 63.166666666666664
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 88.53333333333335
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 162.43333333333334
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 105.90000000000002
GSM27494 CTL_a (control, 1st replicate) 69.23333333333333
GSM27495 CTL_b (control, 2nd replicate) 68.03333333333333
GSM27496 CTL_c (control, 3rd replicate) 70.3
GSM27497 CTL_d (control, 4th replicate) 72.96666666666667
GSM27498 CTL_e (control, 5th replicate) 115.0
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 111.13333333333333
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 107.13333333333333
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 66.16666666666667
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 81.0
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 71.60000000000001
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 119.83333333333333
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 129.76666666666665
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 87.36666666666667
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 78.5
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 196.33333333333334
GSM27509 ISCH_a (ischemia, 1st replicate) 114.73333333333333
GSM27510 ISCH_b (ischemia, 2nd replicate) 47.5
GSM27511 ISCH_c (ischemia, 3rd replicate) 119.83333333333333
GSM27512 ISCH_d (ischemia, 4th replicate) 66.06666666666666
GSM27513 ISCH_e (ischemia, 5th replicate) 88.86666666666667

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 278.0
GSM30791 baseline control 02 male, 275-300g 396.0
GSM30792 baseline control 03 male, 275-300g 257.4
GSM30793 baseline control 04 male, 275-300g 326.6
GSM30794 baseline control 05 male, 275-300g 259.0
GSM30795 baseline control 06 male, 275-300g 236.1
GSM30796 baseline control 07 male, 275-300g 289.8
GSM30797 baseline control 08 male, 275-300g 298.3
GSM30798 baseline control 09 male, 275-300g 346.4
GSM30799 pain 01 337.6
GSM30800 pain 02 372.2
GSM30801 pain 03 383.2
GSM30802 pain 04 253.6
GSM30803 pain 05 314.9
GSM30804 FC 01 385.9
GSM30805 FC 02 329.5
GSM30806 FC 03 317.9
GSM30807 FC 04 306.7
GSM30808 FC 05 311.3
GSM30809 IFC 01 343.2
GSM30810 IFC 02 270.9
GSM30811 IFC 03 230.2
GSM30812 IFC 04 236.3
GSM30813 IFC 05 295.5
GSM99800 isoflurane 01 male, 275-300g 260.6
GSM99801 isoflurane 02 male, 275-300g 343.5
GSM99802 isoflurane 03 male, 275-300g 371.3
GSM99803 isoflurane 04 male, 275-300g 370.7
GSM99804 isoflurane 05 male, 275-300g 116.4

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 34.5578
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 32.1331
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 32.4282
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 46.4466
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 41.7597
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 32.759
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 34.4492
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 32.6442
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 28.859

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 8.83444
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 8.90262
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 8.63349
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 8.34847
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 9.511
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 9.58395
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 10.3005
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 10.7156
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 8.68642
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 8.70046
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 7.68456
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 7.64536
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 9.76593
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 9.11113
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 10.38
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 9.76704

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.055372
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.275064
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.106155
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.252244
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.531657
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.127043
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.334769
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.11916
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.286796
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.985356
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.357516
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.254547
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.220301
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.165507
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.302594
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.210474
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.171638
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.302178
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.082096
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.317586
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.12985
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.167779
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.216163
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.308391
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.280842
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.184222
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.302907
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.071326
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.354151
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.116487
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.151623
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.243876
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.210474
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.054268
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.170116
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.251723
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.104666
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.098288
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.169943
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.441283
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.378808
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.491809
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.15243
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.190144
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.316985

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 148.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 153.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 142.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 123.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 150.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 112.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 156.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 129.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 110.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 173.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 115.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 142.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 163.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 174.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 166.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 144.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 111.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 132.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 108.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 107.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 154.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 189.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 146.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 132.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 149.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 120.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 126.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 115.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 150.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 186.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 140.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 176.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 180.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 154.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 193.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 134.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 0.0
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.0
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 0.0
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 0.076688

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.0589
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.027849999999999996
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.0177
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 -0.3295
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.030545000000000003
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.01125
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.05115
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0476
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.033100000000000004
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.0051
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.025195000000000002
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.08635000000000001

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 48.03333333333333
GSM5121 Isoflurane single exposure control-2 34.13333333333333
GSM5122 Isoflurane single exposure control-3 35.03333333333334
GSM5124 Isoflurane single exposure 1 hr-1 50.9
GSM5126 Isoflurane single exposure 1 hr-2 36.833333333333336
GSM5127 Isoflurane single exposure 2 hr-1 45.73333333333333
GSM5130 Isoflurane single exposure 2 hr-2 37.96666666666667
GSM5131 Isoflurane single exposure 2 hr-3 40.46666666666667

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.682071255
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.302058605
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.865385543
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.552688877
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.385506249
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.990956347
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.887565318
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.554418003
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.494360789
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.670275536
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.742783462
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.774836246
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.622802534
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.928157171
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.394027049
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.640342772
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.989357402
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.540021124
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.676939915
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.678715191
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.978613487
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.871650855
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.502562671
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.622132454

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.202303
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.172685
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.078459
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.081272
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.046272
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.057615
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.014708
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.1778
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.074333
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.899413
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.002711
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.276323
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.069932
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.069105
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.961298
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.184227
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.977731
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.082337
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.993617
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.453228
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.099405
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.023253
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.069742
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.161716

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 136.1124
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 157.4734

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 184.1143656
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 130.6011961
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 299.2962438
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 103.4008019
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 123.6117797
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 63.25576513
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 232.4448671
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 172.0309905
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 210.2646503
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 208.4765044
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 81.02151174
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 296.7566066
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 183.2277177
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 19.04872371

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.682071255
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.302058605
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.865385543
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.552688877
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.385506249
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.990956347
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.887565318
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.554418003
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.494360789
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.670275536
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.742783462
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.774836246
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.622802534
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.928157171
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.394027049
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.640342772
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.989357402
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.540021124
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.676939915
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.678715191
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.978613487
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.871650855
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.502562671
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.622132454
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 184.1143656
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 130.6011961
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 299.2962438
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 103.4008019
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 123.6117797
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 63.25576513
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 232.4448671
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 172.0309905
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 210.2646503
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 208.4765044
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 81.02151174
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 296.7566066
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 183.2277177
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 19.04872371

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 65.03333333333333
GSM5084 Control 2 48.166666666666664
GSM5085 Control 3 58.5
GSM5086 Control 4 65.23333333333333
GSM5087 Control 5 66.10000000000001
GSM5090 Control 6 75.26666666666667
GSM5105 Control 7 56.699999999999996
GSM5106 Control 8 62.199999999999996
GSM5107 Control 9 53.03333333333334
GSM5108 Halothane 10 exposure-1 57.400000000000006
GSM5109 Halothane 10 exposures-2 56.43333333333333
GSM5110 Halothane 10 exposures-3 56.699999999999996
GSM5111 Halothane 5 exposures-1 58.73333333333333
GSM5112 Halothane 5 exposures-2 65.93333333333334
GSM5113 Halothane 5 exposures-3 56.36666666666667
GSM5114 Isoflurane 10 exposures-1 53.6
GSM5115 Isoflurane 10 exposures-2 69.46666666666667
GSM5116 Isoflurane 10 exposures-3 42.46666666666667
GSM5117 Isoflurane 5 exposures-1 52.46666666666667
GSM5118 Isoflurane 5 exposures-2 62.0
GSM5119 Isoflurane 5 exposures-3 55.43333333333334
GSM11379 Control 10 54.96666666666666
GSM11380 Control 11 62.96666666666667
GSM11381 Control 12 58.9

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 2.89869
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 7.14886